KEAP1 and nasopharyngeal carcinoma: In Epstein–Barr virus (EBV)-positive NPC cells, EBV infection was found to stabilize Nrf2 via the p62–Keap1–Nrf2 pathway, leading to elevated SLC7A11 and GPX4 expression [55].